In today's edition of Market Checkup, health-care analysts David Williamson and Max Macaluso take a close look at Merck, a Dow component and one of the biggest players in the pharmaceutical industry. They analyze the highlights from Merck's second-quarter results and examine the company's main vulnerabilities.